| 1 |
Priwitaningrum DL, Pednekar K, Gabriël AV, Varela-Moreira AA, Le Gac S, Vellekoop I, Storm G, Hennink WE, Prakash J. Evaluation of paclitaxel-loaded polymeric nanoparticles in 3D tumor model: impact of tumor stroma on penetration and efficacy. Drug Deliv Transl Res 2023. [PMID: 36853438 DOI: 10.1007/s13346-023-01310-1] [Reference Citation Analysis]
|
| 2 |
Gomez-Cruz C, Laguna S, Bachiller-Pulido A, Quilez C, Cañadas-Ortega M, Albert-Smet I, Ripoll J, Muñoz-Barrutia A. Single Plane Illumination Microscopy for Microfluidic Device Imaging. Biosensors (Basel) 2022;12. [PMID: 36551076 DOI: 10.3390/bios12121110] [Reference Citation Analysis]
|
| 3 |
Alves CG, Lima-Sousa R, Melo BL, Ferreira P, Moreira AF, Correia IJ, Melo-Diogo D. Poly(2-ethyl-2-oxazoline)-IR780 conjugate nanoparticles for breast cancer phototherapy. Nanomedicine (Lond) 2022;17:2057-72. [PMID: 36803049 DOI: 10.2217/nnm-2022-0218] [Reference Citation Analysis]
|
| 4 |
Tutty MA, Vella G, Prina-Mello A. Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity. Drug Deliv Transl Res 2022. [PMID: 35763196 DOI: 10.1007/s13346-022-01170-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Baião A, Dias S, Soares AF, Pereira CL, Oliveira C, Sarmento B. Advances in the use of 3D colorectal cancer models for novel drug discovery. Expert Opin Drug Discov 2022;:1-12. [PMID: 35343351 DOI: 10.1080/17460441.2022.2056162] [Reference Citation Analysis]
|
| 6 |
Baniahmad A. Tumor spheroids and organoids as preclinical model systems. Medizinische Genetik 2021;33:229-34. [DOI: 10.1515/medgen-2021-2093] [Reference Citation Analysis]
|
| 7 |
Lima-Sousa R, Alves CG, Melo BL, Moreira AF, Mendonça AG, Correia IJ, de Melo-Diogo D. Poly(2-ethyl-2-oxazoline) functionalized reduced graphene oxide: Optimization of the reduction process using dopamine and application in cancer photothermal therapy. Mater Sci Eng C Mater Biol Appl 2021;130:112468. [PMID: 34702543 DOI: 10.1016/j.msec.2021.112468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Prasad M, Kumar R, Buragohain L, Kumari A, Ghosh M. Organoid Technology: A Reliable Developmental Biology Tool for Organ-Specific Nanotoxicity Evaluation. Front Cell Dev Biol 2021;9:696668. [PMID: 34631696 DOI: 10.3389/fcell.2021.696668] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Massoumi B, Mossavi R, Motamedi S, Derakhshankhah H, Vandghanooni S, Jaymand M. Fabrication of a dual stimuli-responsive magnetic nanohydrogel for delivery of anticancer drugs. Drug Dev Ind Pharm 2021;:1-9. [PMID: 34590962 DOI: 10.1080/03639045.2021.1988099] [Reference Citation Analysis]
|
| 10 |
Castro F, Leite Pereira C, Helena Macedo M, Almeida A, José Silveira M, Dias S, Patrícia Cardoso A, José Oliveira M, Sarmento B. Advances on colorectal cancer 3D models: The needed translational technology for nanomedicine screening. Adv Drug Deliv Rev 2021;175:113824. [PMID: 34090966 DOI: 10.1016/j.addr.2021.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 11 |
Khawar IA, Ghosh T, Park JK, Kuh H. Tumor spheroid-based microtumor models for preclinical evaluation of anticancer nanomedicines. J Pharm Investig 2021;51:541-53. [DOI: 10.1007/s40005-021-00534-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Trivedi P, Liu R, Bi H, Xu C, Rosenholm JM, Åkerfelt M. 3D Modeling of Epithelial Tumors-The Synergy between Materials Engineering, 3D Bioprinting, High-Content Imaging, and Nanotechnology. Int J Mol Sci 2021;22:6225. [PMID: 34207601 DOI: 10.3390/ijms22126225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Boix-Montesinos P, Soriano-Teruel PM, Armiñán A, Orzáez M, Vicent MJ. The past, present, and future of breast cancer models for nanomedicine development. Adv Drug Deliv Rev 2021;173:306-30. [PMID: 33798642 DOI: 10.1016/j.addr.2021.03.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 14 |
Bromma K, Alhussan A, Perez MM, Howard P, Beckham W, Chithrani DB. Three-Dimensional Tumor Spheroids as a Tool for Reliable Investigation of Combined Gold Nanoparticle and Docetaxel Treatment. Cancers (Basel) 2021;13:1465. [PMID: 33806801 DOI: 10.3390/cancers13061465] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 15 |
Luiz MT, Viegas JSR, Abriata JP, Tofani LB, Vaidergorn MM, Emery FDS, Chorilli M, Marchetti JM. Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment. Mater Sci Eng C Mater Biol Appl 2021;124:112033. [PMID: 33947535 DOI: 10.1016/j.msec.2021.112033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
